(Q37101287)

18 August 2017

1 reference

title

A shift from adaptive to innate immunity: a potential mechanism of disease progression in multiple sclerosis (English)

1 reference

18 August 2017

0 references

Howard L Weiner

1

1 reference

PubMed ID

18317671

18 August 2017

language of work or name

1 reference

1 March 2008

1 reference

18 August 2017

1 reference

18 August 2017

255 Suppl 1

1 reference

18 August 2017

3-11

1 reference

https://scigraph.springernature.com/pub.10.1007/s00415-008-1002-8

18 August 2017

0 references

cites work

Increased interleukin 12 production in progressive multiple sclerosis: induction by activated CD4+ T cells via CD40 ligand

1 reference

12 December 2020

IL-18 is linked to raised IFN-gamma in multiple sclerosis and is induced by activated CD4(+) T cells via CD40-CD40 ligand interactions

1 reference

12 December 2020

Benign course in multiple sclerosis: a review.

1 reference

12 December 2020

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

1 reference

12 December 2020

Multiple sclerosis: comparison of copolymer-1- reactive T cell lines from treated and untreated subjects reveals cytokine shift from T helper 1 to T helper 2 cells

1 reference

12 December 2020

Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4+ CD25- LAP+ T cells.

1 reference

12 December 2020

Glatiramer acetate: mechanisms of action in multiple sclerosis

1 reference

12 December 2020

Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus

1 reference

12 December 2020

Genetics of multiple sclerosis

1 reference

12 December 2020

Th17: an effector CD4 T cell lineage with regulatory T cell ties

1 reference

12 December 2020

Treatment of acute renal allograft rejection with OKT3 monoclonal antibody

1 reference

12 December 2020

Muromonab CD3: a reappraisal of its pharmacology and use as prophylaxis of solid organ transplant rejection

1 reference

12 December 2020

Risk alleles for multiple sclerosis identified by a genomewide study

1 reference

12 December 2020

Genetics in multiple sclerosis: past and future perspectives.

1 reference

12 December 2020

A model for the comprehensive investigation of a chronic autoimmune disease: the multiple sclerosis CLIMB study

1 reference

12 December 2020

Inhibition of autoimmune diabetes by oral administration of anti-CD3 monoclonal antibody

1 reference

12 December 2020

Induction of CD4+CD25+ regulatory T cells by copolymer-I through activation of transcription factor Foxp3

1 reference

12 December 2020

Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis

1 reference

12 December 2020

Effect of glatiramer acetate (Copaxone) on CD4+CD25high T regulatory cells and their IL-10 production in multiple sclerosis

1 reference

12 December 2020

Innate immunity in multiple sclerosis: myeloid dendritic cells in secondary progressive multiple sclerosis are activated and drive a proinflammatory immune response

1 reference

12 December 2020

10.1007/S00415-008-1002-8

Identifiers

DOI

1 reference

release_dz53nuylefha7geujw5edlhxia

18 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dz53nuylefha7geujw5edlhxia

24 November 2022

mapped directly with Wikidata item

PubMed ID

18317671

1 reference

PubMed ID

18317671